LISATA THERAPEUTICS, INC. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
LISATA THERAPEUTICS, INC. (LSTA) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 1.23 million shares as of 2022-09-15, per its 10-K filed 2024-02-29.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2024-02-29
- 2022-09-15: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 1.23M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2022-09-15 | 1.23M shares 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |